Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer research

Showing results (1-10 of 49,939) with videos related to

Pageof 4,994
Sort By:
Cancer Research|August 28, 2001
Amifostine protects against early but not late toxic effects of doxorubicin in infant ratsK Jahnukainen, T Jahnukainen, T T Salmi, et al.
Cancer Research|August 28, 2001
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicinY Li, D C Yu, Y Chen, et al.
Cancer Research|August 28, 2001
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cellsK E Luker, C M Pica, R D Schreiber, et al.
Cancer Research|August 28, 2001
Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivationN Akakura, M Kobayashi, I Horiuchi, et al.
Cancer Research|August 28, 2001
Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cellsH Roh, D W Green, C B Boswell, et al.
Cancer Research|September 18, 2001
Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2P Kunkel, U Ulbricht, P Bohlen, et al.
Cancer Research|September 18, 2001
APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosisA I Robles, N A Bemmels, A B Foraker, et al.
Cancer Research|September 18, 2001
HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumorsH M Sowter, P J Ratcliffe, P Watson, et al.
Cancer Research|September 18, 2001
The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeabilityD A Beauregard, S A Hill, D J Chaplin, et al.
Cancer Research|September 18, 2001
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinomaE C Ibrahim, N Guerra, M J Lacombe, et al.
Pageof 4,994

Showing results (1-10 of 49,939) with videos related to

Sort By:
Pageof 4,994
Cancer Research|August 28, 2001
Amifostine protects against early but not late toxic effects of doxorubicin in infant ratsK Jahnukainen, T Jahnukainen, T T Salmi, et al.
Cancer Research|August 28, 2001
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicinY Li, D C Yu, Y Chen, et al.
Cancer Research|August 28, 2001
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cellsK E Luker, C M Pica, R D Schreiber, et al.
Cancer Research|August 28, 2001
Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivationN Akakura, M Kobayashi, I Horiuchi, et al.
Cancer Research|August 28, 2001
Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cellsH Roh, D W Green, C B Boswell, et al.
Cancer Research|September 18, 2001
Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2P Kunkel, U Ulbricht, P Bohlen, et al.
Cancer Research|September 18, 2001
APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosisA I Robles, N A Bemmels, A B Foraker, et al.
Cancer Research|September 18, 2001
HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumorsH M Sowter, P J Ratcliffe, P Watson, et al.
Cancer Research|September 18, 2001
The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeabilityD A Beauregard, S A Hill, D J Chaplin, et al.
Cancer Research|September 18, 2001
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinomaE C Ibrahim, N Guerra, M J Lacombe, et al.
Pageof 4,994